We are live on ! Find out more
ICRM

Insight Capital Research & Management Portfolio holdings

AUM $177M
1-Year Est. Return 72%
This Fund
S&P 500
This Quarter Est. Return
+18.8%
1 Year Est. Return
+72%
3 Year Est. Return
+286.87%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$225M
AUM Growth
-$62.3M
Cap. Flow
-$86.1M
Cap. Flow %
-38.32%
Top 10 Hldgs %
23.41%
Holding
144
New
47
Increased
8
Reduced
37
Closed
49

Top Buys

Rank Stock Value
1
AXON
Axon Enterprise
AXON
+$5.41M
2
COHR
Coherent Inc
COHR
+$4.84M
3
MTZ icon
MasTec
MTZ
+$4.77M
4
VEEV icon
Veeva Systems
VEEV
+$4.68M
5
BABA icon
Alibaba
BABA
+$3.57M

Top Sells

Rank Stock Value
1
CONE
CyrusOne Inc Common Stock
CONE
+$7.12M
2
CYNO
Cynosure, Inc. Class A
CYNO
+$5.75M
3
BSX icon
Boston Scientific
BSX
+$5.42M
4
FN icon
Fabrinet
FN
+$4.81M
5
GVA icon
Granite Construction
GVA
+$4.45M

Sector Composition

Rank Sector Weight
1 Technology 25.6%
2 Industrials 22.86%
3 Healthcare 16.54%
4 Consumer Discretionary 12.84%
5 Communication Services 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TMO icon
126
Thermo Fisher Scientific
TMO
$220B
– –
-17,851
Closed -$2.64M
TTC icon
127
Toro Company
TTC
$9.49B
– –
-70,994
Closed -$3.13M
TYL icon
128
Tyler Technologies
TYL
$12.8B
– –
-7,941
Closed -$1.32M
VMC icon
129
Vulcan Materials
VMC
$36.9B
– –
-19,058
Closed -$2.29M
VZ icon
130
Verizon
VZ
$196B
– –
-34,243
Closed -$1.91M
WST icon
131
West Pharmaceutical
WST
$24.9B
– –
-32,551
Closed -$2.47M
SYNH
132
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-67,202
Closed -$2.56M
FRC
133
DELISTED
First Republic Bank
FRC
– –
-60,421
Closed -$4.23M
CONE
134
DELISTED
CyrusOne Inc Common Stock
CONE
– –
-127,894
Closed -$7.12M
COR
135
DELISTED
Coresite Realty Corporation
COR
– –
-45,306
Closed -$4.02M
CORE
136
DELISTED
Core Mark Holding Co., Inc.
CORE
– –
-56,818
Closed -$2.66M
USCR
137
DELISTED
U S Concrete, Inc.
USCR
– –
-52,207
Closed -$3.18M
PRAH
138
DELISTED
PRA Health Sciences, Inc.
PRAH
– –
-62,387
Closed -$2.6M
CBM
139
DELISTED
Cambrex Corporation
CBM
– –
-63,226
Closed -$3.27M
GIMO
140
DELISTED
Gigamon Inc.
GIMO
– –
-102,393
Closed -$3.83M
WBMD
141
DELISTED
WebMD Health Corp.
WBMD
– –
-23,615
Closed -$1.37M
CYNO
142
DELISTED
Cynosure, Inc. Class A
CYNO
– –
-118,116
Closed -$5.75M
DOC
143
DELISTED
PHYSICIANS REALTY TRUST
DOC
– –
-143,830
Closed -$3.02M
WOOF
144
DELISTED
VCA Inc.
WOOF
– –
-62,586
Closed -$4.23M
2 3 4 5
6

Similar funds

YP
YG Partners New York $189M AUM 21.34% 1-Year Est. Return
PCMI
Princeton Capital Management Inc Princeton, New Jersey $198M AUM 28.98% 1-Year Est. Return
BSWMG
Barrington Strategic Wealth Management Group Chicago, Illinois $198M AUM 10.24% 1-Year Est. Return
OW
Orbis World Road Town, Tortola, British Virgin Islands $154M AUM 2.78% 1-Year Est. Return
QI
Quotient Investors New York $146M AUM 15.98% 1-Year Est. Return
TGCM
Tukman Grossman Capital Management Larkspur, California $133M AUM 15.1% 1-Year Est. Return
TG
Threshold Group Seattle, Washington $125M AUM 14.58% 1-Year Est. Return
MIM
Midwest Investment Management Cleveland, Ohio $121M AUM 20.45% 1-Year Est. Return

Insight Capital Research & Management's Q3 2016 Portfolio in Review

As of Q3 2016, Insight Capital Research & Management held 144 positions worth $225M, down 22% from $287M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Insight Capital Research & Management withdrew a net $86.1M in Q3 2016, closing 49 positions and reducing 37 holdings. Its most notable exit was CyrusOne Inc Common Stock, an estimated $7.12M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Insight Capital Research & Management opened a new position in Axon Enterprise worth $5.57M.

  • Insight Capital Research & Management's largest Q3 2016 buy was Axon Enterprise: 194,663 shares worth $5.57M.
  • Insight Capital Research & Management added most to Thor Industries in Q3 2016, an estimated $2.34M increase.
  • Insight Capital Research & Management's biggest Q3 2016 reduction was Boston Scientific, cutting an estimated $5.42M.
  • Insight Capital Research & Management fully exited CyrusOne Inc Common Stock in Q3 2016, selling an estimated $7.12M.
  • Insight Capital Research & Management's ten largest holdings make up 23% of its $225M portfolio in Q3 2016.
  • Insight Capital Research & Management opened 47 new positions and closed 49 in Q3 2016.
  • Insight Capital Research & Management's portfolio value fell 22% quarter-over-quarter to $225M.

Based on Insight Capital Research & Management's 13F filing for Q3 2016, filed 24 Oct 2016.